The DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index; 9 of the 16 sources its claims cite were checked for support.
Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples
Open accessAbstract
BACKGROUND: The detection of nitazene compounds in the United Kingdom has raised concerns among healthcare professionals, public health authorities, and law enforcement due to the increased risk of fatal overdose, particularly among opioid users. In response, nitazene testing strips have been distributed to help users identify these substances in drugs they may consume. However, to date, limited testing has been conducted on the effectiveness of these strips. METHODS: This study assesses the sensitivity and selectivity of a widely distributed nitazene immunoassay drug testing strip. The limit of detection and selectivity was examined for 36 nitazene analogs and 93 other drugs and cutting agents commonly encountered in illicit samples. The effectiveness of the test strips for the detection of metonitazene in the presence of other drugs was examined using a series of concentrations in solution in combination with other drugs. Testing of the strips was also carried out using authentic seized heroin samples. RESULTS: The strips detected 28 out of 36 nitazene compounds (78%) with detection limits ranging from 250 ng/mL to 100 µg/mL. The strips did not provide positive results for 93 other drugs and cutting agents at a concentration of 100 µg/mL. However, false positives were observed when testing seized heroin samples, caused by caffeine concentrations over 300 µg/mL. False negatives were also seen for eight nitazene compounds. CONCLUSION: Caution should be exercised when deploying these nitazene test strips as frontline presumptive tests in both criminal justice and public health contexts due to the observed false negative and false positive results. While the strips successfully detected a majority of nitazene compounds, their inability to identify certain analogs poses a risk of not detecting the presence of these potent opioids in the drug supply. Additionally, the occurrence of false positives, due to the presence of caffeine-a common adulterant in illicit substances-raises concerns about their suitability for use as a harm reduction method.
Overview
CoChat Summary
TL;DR
This laboratory evaluation found that BTNX Rapid Response™ nitazene test strips detected 28 of 36 nitazene analogs (78%) but missed eight and showed caffeine-related false positives with seized heroin samples. The authors caution that false negatives, variable limits of detection, and caffeine cross-reactivity limit the strips’ suitability as frontline presumptive tests in harm reduction and criminal justice settings.
Key findings
- The strips detected 28/36 nitazene compounds (78%), with limits of detection ranging from 250 ng/mL to 100 µg/mL; eight nitazenes were not detected, including etazene, metodesnitazene, protodesnitazene, and 5-aminoisotonitazene.
- No positive results were produced for 93 other drugs and cutting agents at 100 µg/mL, and metonitazene at 1300 ng/mL was detected in all mixtures containing 100 µg/mL of the listed drugs/cutting agents.
- Seized heroin samples contained no nitazenes by GC–MS but produced faded test lines; caffeine cross-reactivity began at approximately 300 µg/mL and caused a false positive between 7 and 10 mg/mL. Estimated caffeine content in the seized samples was 21.9–24.7%, corresponding to 262–321 µg/mL in the 1 mg/mL test solutions.
- Study LODs were 1500 ng/mL for isotonitazene, 3000 ng/mL for protonitazene HCl, and 1500 ng/mL for N-pyrrolidino etonitazene, compared with manufacturer-reported values of 2000, 3000, and 1300 ng/mL, respectively.
Methods
- The study evaluated Rapid Response™ Nitazene Test Strips (BTNX, lots DOAB24050015 and DOAB24020005) using tap water; 36 nitazene analogs and 93 other drugs/cutting agents were tested at 100 µg/mL, and LODs were determined by serial 1-in-2 dilutions tested in triplicate, with LOD defined as the lowest concentration at which all replicates were positive.
- Metonitazene detection in mixtures was assessed at 1300 ng/mL with 100 µg/mL of other compounds, and three authentic seized heroin samples from the Scottish Prison Service were dissolved at 1 mg/mL and tested, with GC–MS data used to confirm absence of nitazenes.
- Test strips were read visually according to manufacturer instructions: one visible line was positive, two lines negative, and invalid strips were repeated.
Limitations
- The paper states that limited access to authentic seized samples containing nitazenes meant the strips could not be evaluated with such materials; the drug panel reflected the UK illicit market, so cross-reactivity with all potential compounds was not assessed, and further assessment is needed as additional nitazenes emerge.
- The text makes evident that visual interpretation of faint test lines is subjective and may be difficult in harm reduction settings, where image-processing aids such as ImageJ are described as unrealistic.
- The paper cites prior work showing batch-to-batch LOD variation, but this study does not report lot-specific comparisons despite using two strip lots.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
2 Valid · 7 Not valid · 7 Not checked · 49 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“De Vrieze et al. [22] examined the efficacy of the test strips using seized samples in Ghent. These samples composed of either metonitazene, protonitazene, isotonitazene, butonitazene, or N-pyrrolidino etonitazene with an estimated purity of > 90%.”
§ Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples > Discussion
What the sources say
- Disputedcites [22] Sisco E, Appley MG, Pyfrom EM, Banta-Green CJ, Shover CL, Molina CA, et al. Beyond fentanyl test strips: investigating other urine drug test strips for drug checking applications. Forensic Chem. 2024;40:100594. sourceExperimental — accuracy not yet measured
The Conclusions (page unavailable) explicitly state that this study did not investigate real-world samples or mixtures, contrary to the claim that it tested seized samples in Ghent. Materials & Methods describes prepared analyte solutions, and the paper provides no support for the claimed sample composition or >90% purity. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“This study, and previous studies such as Sisco et al. (2024) found no cross reactivity of the test strips with diamorphine, papaverine, acetylcodeine, 6-monoacetylmorphine (6-MAM), noscapine, caffeine or paracetamol at 100,000 ng/mL.”
§ Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples > Results > Analysis of seized heroin samples
What the sources say
- Disputedcites Sisco et al. (2024) sourceExperimental — accuracy not yet measured
The Results and Discussion (Cross-Reactivity; page unavailable) report that opiate test strips gave positive results for 6-monoacetylmorphine, contrary to the claimed absence of cross-reactivity. Materials & Methods (Cross-Reactivity; page unavailable) also specifies testing at 10,000 and either 500,000 or 1,000,000 ng/mL, not 100,000 ng/mL. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“metodesnitazene, detected in one death reported in England by the Office of Health Improvement and Disparities (OHID) in 2024 [20]”
§ Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples > Discussion
What the sources say
- Could not verifycites [20] Żubrycka A, Kwaśnica A, Haczkiewicz M, Sipa K, Rudnicki K, Skrzypek S, et al. Illicit drugs street samples and their cutting agents. The result of the GC-MS based profiling define the guidelines for sensors development. Talanta. 2022;237:122904. sourceExperimental — accuracy not yet measured
The Results and discussion section reports GC-MS findings from illicit-drug street samples, not deaths in England. Searches of our copy for metodesnitazene and for an OHID report of a 2024 death found no passage addressing the claim; the paper was published in 2022. (LLM, conf=0.78)
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Overall, the LOD and cross-reactivity results observed in this study were largely consistent with those reported by De Vrieze et al. [22]”
§ Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples > Discussion
What the sources say
- Partly supportedcites [22] Sisco E, Appley MG, Pyfrom EM, Banta-Green CJ, Shover CL, Molina CA, et al. Beyond fentanyl test strips: investigating other urine drug test strips for drug checking applications. Forensic Chem. 2024;40:100594. sourceExperimental — accuracy not yet measured
The Results and Discussion sections on Limit of Detection and Cross-Reactivity report both kinds of test-strip results. But the cited paper is Sisco et al., not De Vrieze et al., and our copy does not compare its results with De Vrieze’s or establish the claimed consistency. No page numbers are available in our copy. (LLM, conf=0.81)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“De Vrieze et al. [22] reported cross-reactivity at 3 µg/mL.”
§ Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples > Discussion
What the sources say
- Could not verifycites [22] Sisco E, Appley MG, Pyfrom EM, Banta-Green CJ, Shover CL, Molina CA, et al. Beyond fentanyl test strips: investigating other urine drug test strips for drug checking applications. Forensic Chem. 2024;40:100594. sourceExperimental — accuracy not yet measured
The Cross-Reactivity and Limit of Detection sections discuss nitazene test strips, but do not report a result for 5-methyl etazene at 3 µg/mL. Searches for “De Vrieze,” “5-methyl etazene,” and the stated concentration found no passage addressing the attributed finding; page numbers were unavailable in our copy. (LLM, conf=0.76)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
40 more claims · 1 with their cited sources checked
Create a free account to see all 65 claims and to verify the 2 references still open.
- Probably not a substantial claim. 11
- It may state two separate claims as one. 9
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A major challenge in detecting nitazene exposure is that these compounds are frequently missed by routine hospital immunoassay drug screening panels [41].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nitazenes may be present alone or in combination with other novel psychoactive substances, which further causes more toxicity [41, 44].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, testing was conducted using high‐purity samples, which may not reflect the complexity of real‐world polysubstance mixtures.”
From Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024 (2026) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Similarly, another study demonstrated reliable detection of 28 of 36 nitazene analogs, with limits of detection ranging from 250 ng/mL to 100 μg/mL [43].”
From Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024 (2026) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“For example, one study reported false‐positive results in the presence of caffeine (a common adulterant) at concentrations exceeding 300 μg/mL, raising concerns about the accuracy of nitazene detection in polysubstance mixtures [43].”
From Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024 (2026) · cites this paper as [43]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples > Abstract > Results
“However, false positives were observed when testing seized heroin samples, caused by caffeine concentrations over 300 µg/mL.”
§ Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples > Results > Analysis of seized heroin samples
“Each of the seized samples did present a faint line (Fig. 2) and by manufacturer’s guidelines were therefore providing a true negative result.”
Citations
Cites
Green, T. C., Park, J. N., Gilbert, M., McKenzie, M., Struth, E., Lucas, R., Clarke, W., & Sherman, S. G. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102661 · Cited by 211 · cited 1×
“However previous studies have suggested that compounds can start to interfere with immunoassay test strips at higher concentrations [17, 18].”
Use of rapid fentanyl test strips among young adults who use drugs
Krieger, M. S., Goedel, W. C., Buxton, J. A., Lysyshyn, M., Bernstein, E., Sherman, S. G., Rich, J. D., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.09.009 · Cited by 187
Goldman, J. E., Waye, K. M., Periera, K. A., Krieger, M. S., Yedinak, J. L., & Marshall, B. D. L. (2019) · Harm Reduction Journal · doi:10.1186/s12954-018-0276-0 · Cited by 183
Fentanyl shock: The changing geography of overdose in the United States
Zoorob, M. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.04.010 · Cited by 160 · cited 1×
“To date, opiate drug related deaths within the United Kingdom and Scotland, have not been as heavily impacted by the rise of synthetic opioids such as fentanyl and their analogues, as has been evidenced in other countries including the United States [2, 3].”
High willingness to use rapid fentanyl test strips among young adults who use drugs
Krieger, M. S., Yedinak, J. L., Buxton, J. A., Lysyshyn, M., Bernstein, E., Rich, J. D., Green, T. C., Hadland, S. E., & Marshall, B. D. L. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0213-2 · Cited by 142 · cited 3×
“The use of commercially available testing strips has been previously investigated as a harm reduction strategy, most recently to address the DRDs associated with fentanyl in the USA and Canada [11–14].”
Montanari, E., Madeo, G., Pichini, S., Busardò, F. P., & Carlier, J. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000970 · Cited by 89 · cited 4×
“…agents were selected based on those mostly commonly detected within non-judicial samples from Scottish Prisons and those mostly commonly detected in mixtures with nitazenes as reported in samples submitted to the Welsh Emerging Drugs and Identification of Novel Substances Project (WEDINOS) [9].”
InfluentialNitazenes—Heralding a Second Wave for the UK Drug-Related Death Crisis?
Holland, A., Copeland, C. S., Shorter, G. W., Connolly, D. J., Wiseman, A., Mooney, J., Fenton, K., & Harris, M. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00001-x · Cited by 86 · cited 2×
“DRDs in Scotland in 2023 [3–5].”
Lockwood, T.-L. E., Vervoordt, A., & Lieberman, M. (2021) · Harm Reduction Journal · doi:10.1186/s12954-021-00478-4 · Cited by 85 · cited 1×
“This study highlights a significant challenge for harm reduction services, as caffeine is one of the most commonly detected cutting agents in illicit drug samples, including street heroin, cocaine, and amphetamines [19].”
Old Drugs and New Challenges: A Narrative Review of Nitazenes
Pergolizzi Jr, J., Raffa, R., LeQuang, J. A. K., Breve, F., & Varrassi, G. (2023) · Cureus · doi:10.7759/cureus.40736 · Cited by 81
Hunger, A., Kebrle, J., Rossi, A., & Hoffmann, K. J. (1960) · Helvetica Chimica Acta · doi:10.1002/hlca.19600430412 · Cited by 70 · cited 1×
“Nitazene compounds are frequently found in combination with other opioids such as diamorphine as part of heroin mixtures and as such it is unlikely that users will have any knowledge that they are administering a nitazene containing substance, much less the specific nitazene in question [8].”
Cited by
Zhu, D. T., Fitzgerald, N. D., Palamar, J. J., & Krotulski, A. J. (2026) · Addiction · doi:10.1111/add.70378 · Cited by 8
“Finally, the absence of demographic or clinical information precludes more detailed analysis of individual-level health effects and public health implications.”
Mayer, A., Montgomery, N., Hughes, E., Birks Ang, B., & Johnson, O. E. (2026) · Forensic Science International · doi:10.1016/j.forsciint.2025.112717 · Cited by 4
Hardwick, E. K., Couch, A. N., & Davidson, J. T. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.70004 · Cited by 1
“Nitazene analogs are a recent example of an emerging class of novel synthetic opioids (NSOs) that are difficult to differentiate due to similar mass spectra, requiring screening methods other than the traditional color tests or immunoassays [8–10].”
Al-Juhani, A., Alasmari, A., Aljohani, O. O., Hakeem, H., Desoky, R., Badghaish, M. A., Aljohani, N., & Alanazi, F. A. (2025) · Cureus · doi:10.7759/cureus.99109 · Cited by 1
“Isotonitazene demonstrated a limit of detection (LOD) ranging from 2000 to 3000 ng/mL, with uniform cross-reactivity at or below 3000 ng/mL, as reported by De Vrieze (2024) [1], Marland (2025) [2], and Sisco (2024) [5].”
InfluentialIdentification of isotocyanozene at an Australian drug checking service
Curtis, B., Lawes, D. J., Persson, M., Caldicott, D. G. E., Gréen, H., Norman, C., & McLeod, M. D. (2026) · Forensic Chemistry · doi:10.1016/j.forc.2026.100744 · Cited by 2
Metadata
- Authors
- Marland, V., Nisbet, L., & Nic Daéid, N.
- Affiliations
- University of Dundee (GB)
- Corresponding author
- Marland, Victoria
- Venue
- Harm Reduction Journal
- Published
- 2025-08-09
- Volume
- 22
- Issue
- 1
- Pages
- 137-137
- ISSN
- 1477-7517 (ISSN-L)
- PMC
- PMC12335075
- OpenAlex
- W4413094431
- Semantic Scholar
- 89ac180a60b9a6b621b5cfbee2e47f5e0ee9cb61
- Cited by
- 21
- References
- 19
- Citations by year
- 2026: 18 · 2025: 3
- FWCI
- 10.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Harm Reduction Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Scottish Prison Service (Procurement Reference 01865)
- The Leverhulme Trust (RC-2015-011)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Keywords
- nitazenes, opioid overdose risk, heroin adulteration, false positives, false-negative results, harm reduction
- MeSH terms
- Humans, Immunoassay, Reagent Strips, Sensitivity and Specificity, Illicit Drugs, Substance Abuse Detection, Limit of Detection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples. https://app.cochat.ai/papers/10.1186/s12954-025-01287-9
- The paper
- Marland, V., Nisbet, L., & Nic Daéid, N. (2025). Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples. Harm Reduction Journal. https://doi.org/10.1186/s12954-025-01287-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.